Clinical Trial Update: BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861) [Phase 2]

View source ↗

Summary

Phase 2 extension study of BG9924 in combination with methotrexate for rheumatoid arthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BG9924
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Biogen | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED